Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan.
about
Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy.The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study.Referring heroin users from compulsory detoxification centers to community methadone maintenance treatment: a comparison of three modelsDifferences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network.Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid DependenceRandomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings.Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.Factors Associated with Relapse among Heroin Addicts: Evidence from a Two-Year Community-Based Follow-Up Study in ChinaEconomic Evaluations of Opioid Use Disorder Interventions.Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement.Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement.Promoting Adoption of Medication for Opioid and Alcohol Use Disorders Through System Change.
P2860
Q33949888-51998580-FE29-4261-ADE8-97EAB4C50BADQ34059799-B6A1CD07-1B1D-4754-B691-D3B6795FFA86Q34929981-919C6378-B33B-479E-A034-74590B1C45C3Q35043378-23B5D40E-5B3E-4ED9-ACDC-CCA9AE24961DQ35065975-85A9150E-2939-4C91-BF24-45421802D73AQ35490468-0A24B57A-C6B6-4C61-AA7B-0CD4ECAB1439Q35751878-CE136E14-B0E9-46B5-8E20-CEB9AD0F31AEQ35871771-AC9CD08C-2C7C-4E97-AF5E-A3A4CCD6EA07Q36619638-509253A0-CB03-451D-AFD9-9E427DE29F27Q36633762-1C7A2312-6441-4D2B-A111-42F0854D1011Q38784603-AF4608C5-4362-4074-9E9F-560145E3AFEDQ39162177-8AEBC80A-9611-4AAF-833F-A5342DFE0679Q44344766-23AF8413-FDD4-4FCD-8BCE-0B2B8B9E8D78Q44349044-137911E1-F53F-4835-B377-02DB25E88AC5
P2860
Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Methadone maintenance and the ...... s in a commercial health plan.
@ast
Methadone maintenance and the ...... s in a commercial health plan.
@en
Methadone maintenance and the ...... s in a commercial health plan.
@nl
type
label
Methadone maintenance and the ...... s in a commercial health plan.
@ast
Methadone maintenance and the ...... s in a commercial health plan.
@en
Methadone maintenance and the ...... s in a commercial health plan.
@nl
prefLabel
Methadone maintenance and the ...... s in a commercial health plan.
@ast
Methadone maintenance and the ...... s in a commercial health plan.
@en
Methadone maintenance and the ...... s in a commercial health plan.
@nl
P2093
P2860
P1476
Methadone maintenance and the ...... s in a commercial health plan.
@en
P2093
Dennis McCarty
Frances Lynch
Michael C Leo
Michael R Polen
Nancy A Perrin
P2860
P304
P356
10.1016/J.DRUGALCDEP.2010.04.018
P407
P577
2010-10-01T00:00:00Z